Risk reduction from HPV vaccination goes beyond cervical cancer #ASCO24
Results from a new study suggest that the human papillomavirus (HPV) vaccine is effective in preventing the development of several types of cancers caused by HPV, most particularly head and…
Artificial Intelligence-Based Patient Navigator May Help Improve Disparities in Colon Cancer Screening #ASCO24
An artificial intelligence-based patient navigator tool demonstrated improved potential in helping to overcome patient attrition that can lead to colon cancer disparities, nearly doubling the rate of completed colonoscopies for…
Estrogen-Only Hormone Therapy may increase cancer risk while Estrogen-Progestin Combination may lower risk #ASCO24
For people who have been through menopause and have taken menopausal hormone therapy, conjugated equine estrogen (CEE) taken alone may increase the risk of developing and dying from ovarian cancer,…
TUMORE AL SENO, SI DIVENTA MAMMA ANCHE DOPO LA TERAPIA #ASCO24
La maggior parte delle sopravvissute al cancro al seno dallo stadio 0 allo stadio III che cercano di concepire, dopo aver completata la terapia, sono in grado di rimanere incinte…
Ricerca: Associazione tra uso di talco nelle zone intime e aumento del rischio di cancro ovarico
Un nuovo studio, pubblicato sul Journal of Clinical Oncology, fornisce prove convincenti che l’uso di talco nelle zone intime è associato ad un aumento del rischio di cancro ovarico. Questa…
ASCO Calls for Global Equity in Cancer Clinical Trials
A new ASCO policy statement is emphasizing the urgent need for global equity in clinical trials. The statement, which published in JCO Global Oncology, explains how global equity can be…